Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (3399)	6/30/1999 5:42:00 PM
From: Biomaven	Read Replies (1) of 10280

Harold, I think Andreas has a partially valid point. Given the ever-present risk of your biotech investment suddenly being worth half (or even less) of what it is today, it is not unreasonable to expect the upside to be uncapped as well. If as soon as a biotech is quarter-way successful it is going to be taken out, the upside appears very much capped. On the other hand, if you look at the takeover real premiums, particularly in AGPH, they were considerably bigger than they at first appeared, given that a big chunk of the premium was already in the price. You would have to have been particularly unlucky in your timing to not have made a pretty substantial return in either AGPH or SUGN. A lot of the smaller biotech stocks have indeed gone nowhere (but down) over the last few years. BTW, I have always thought Andreas to be a pretty sophisticated biotech investor. If you look at his favorite stocks I am sure you will forgive him all. (Hint: BGEN is prominent among them). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next